Daré Bioscience Reports First Quarter 2026 Financial Results and Provides Business Update

Go back to Daré Bioscience Reports First Quarter 2026 Financial Results and Provides Business Update
(NASDAQ: DARE) Delayed: 2.10 +0.05 (2.44%)
Previous Close $2.05    52 Week High
Open $2.02    52 Week Low
Day High $2.14    P/E N/A 
Day Low $2.02    EPS
Volume 48,015